Evidence map›Paper›PMID 41217389›Full record

ArticleJournal of the National Cancer Institute2026

Liquid biopsy for very early detection of HPV-associated oropharyngeal cancer.

David M Routman, Axel M Hidalgo, Aadel A Chaudhuri

Abstract readComment
In one paragraph

Article in Journal of the National Cancer Institute, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

David M RoutmanDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, United States.ORCID 0000-0002-2768-003X
Axel M HidalgoDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, United States.ORCID 0000-0002-1875-5052
Aadel A ChaudhuriDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, United States.ORCID 0000-0003-3115-3061

Funding

MSTP at Mayo Clinic RochesterT32GM145408 · NIGMS · MAYO CLINIC ROCHESTER · PI SCOTT H KAUFMANN, LISA A SCHIMMENTI · 2023 to 2026
$4.7M
Novel ctDNA biomarker for androgen therapy in metastatic prostate cancerR01CA286127 · NCI · WASHINGTON UNIVERSITY · PI Aadel Chaudhuri, Christopher A Maher · 2024 to 2026
$1.8M
Preanalytical Validation of Circulating Tumor DNA from Surgical Drain Fluid as a marker of Postoperative Minimal Residual Disease in Head and Neck Squamous Cell CarcinomaU01CA301249 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Aadel Chaudhuri, Jose P. Zevallos · 2025 to 2026
$707k
NCI NIH HHS R01 CA286127NCI NIH HHS U01 CA301249NIGMS NIH HHS T32 GM145408NIH HHS R01 CA28331NIH HHS R01 CA286127NIH HHS T32 GM145408NIH HHS U01 CA301249US National Institutes of Health R01 CA28331
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41217389
PMCPMC12794210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.